Skip to main content
. 2024 Jun 15;15(6):1091–1110. doi: 10.4239/wjd.v15.i6.1091

Figure 2.

Figure 2

Summary of natural and synthetic compounds for treatment of obesity-related kidney disease. H2S: Hydrogen sulfide; NF-κB: The nuclear factor-kappa B; AMPK: Adenosine 5-monophosphate activated protein kinase; ABCA1: ATP-binding cassette transporter; LPL: Lipoprotein lipase; OSBPL7: Oxysterol binding protein like 7; GRP55: G protein-coupled receptor 55; EPA: Eicosapentaenoic acid; IKK: IκB kinase.